Curtin, F., Champion, B., Davoren, P., Duke, S., Ekinci, E. I., Gilfillan, C., Morbey, C., Nathow, T., O'Moore‐Sullivan, T., O'Neal, D., Roberts, A., Stranks, S., Stuckey, B., Vora, P., Malpass, S., Lloyd, D., Maëstracci‐Beard, N., Buffet, B., Kornmann, G., Bernard, C., Porchet, H., & Simpson, R. (2020). a safety and pharmacodynamics study of temelimab, an antipathogenic human endogenous retrovirus type W envelope monoclonal antibody, in patients with type 1 diabetes. Diabetes, obesity & metabolism, 22(7), 1111–1121. http://access.bl.uk/ark:/81055/vdc_100103798217.0x000020